Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.05.30
关于2017年年报问询函的回复通告
2018.05.30
关于深圳证券生意所对公司的问询函的回复
2018.05.29
关于2017年年报全文的增补通告
2018.05.17
2017年度股东大会决议通告
2018.05.17
2017年度股东大会的执法意见书
2018.05.12
购置资产暨关联生意实验情形报告书
2018.05.12
北京市中伦(深圳)状师事务所关于公司购置资产暨关联生意的实验执法意见书
2018.05.12
中天堂富证券有限公司关于公司购置资产暨关联生意实验情形之自力财务照料核查意见
2018.04.28
关于将宁波银行召募资金专项账户中部分召募资金划转至招商银行召募资金专项账户的通告...
2018.04.28
第四届董事会第十三次聚会决议通告
第一页
上一页
53
54
55
56
57
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】